Carilion Clinic Cardiology is involved in a broad array of cutting-edge research studies. Many of these studies involve novel technologies or therapeutics. As one example, we are participating in a multi-center, international study of a coronary stent that is completely absorbed by the body, leaving no residue. We are involved in studies that will help determine the optimal duration of platelet inhibitors after coronary stenting, testing the effect of novel anti platelet agents, and a completely novel anti-inflammatory agent that may reduce the likelihood of recurrent heart attack. Since we are an academic program that trains new cardiologists, our cardiology fellows will learn about and participate in the research process as part of their education.
Our research studies span the spectrum from large, multi-center randomized clinical trials to smaller studies that were conceived of and conducted by Carilion cardiologists. Our studies are sponsored by the NIH, by device and pharmaceutical companies, by agencies such the American Heart Association and by foundations. Our overall goal is to participate in and conduct studies that will answer important questions in cardiovascular medicine, filling gaps in our current knowledge base.
We have a team of three expert research study coordinators. They comply with all National/International standards of ethics and Good Clinical Practice and are certified through the Society of Clinical Research Associates (SoCRA) as Certified Clinical Research Professionals (C.C.R.P.). All of our studies and consent forms pass through a rigorous approval process by our internal Office of Sponsored Projects department and our Institutional review Board.
We welcome participation by interested individuals in our studies or those who would like to make contributions to support our research efforts.
CURRENT CARDIOLOGY RESEARCH STUDIES
- Azimilide Shield 2
- Effect of Paricalcitol on Coagulation Study (EPOC)
- The DAPT Study
- XIENCE V